39 results
424B3
MDAI
Spectral AI Inc - Ordinary Shares
23 Apr 24
Prospectus supplement
6:10am
in further detail below); and (2) we will pursue the commercialization of the DFU application in the UK, United States and EU4. Our near-term goals related … enable us to meet our technology, IP, clinical, regulatory, and commercial goals in 2024 and beyond.
We have designed and implemented our cash
424B3
MDAI
Spectral AI Inc - Ordinary Shares
23 Apr 24
Prospectus supplement
6:08am
in further detail below); and (2) we will pursue the commercialization of the DFU application in the UK, United States and EU4. Our near-term goals related … enable us to meet our technology, IP, clinical, regulatory, and commercial goals in 2024 and beyond.
We have designed and implemented our cash
424B3
MDAI
Spectral AI Inc - Ordinary Shares
19 Apr 24
Prospectus supplement
1:57pm
be unable to achieve these goals. We may also encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors and risks … commercialization. However, we may be unable to achieve these goals. Approval or clearance from the FDA and comparable regulatory bodies may never be obtained. We
8-K
9mo62op2 ap8y
1 Mar 24
Spectral AI Appoints Peter M. Carlson as CEO
8:00am
S-8
EX-99.2
25vgxb2n hk58y
9 Feb 24
Registration of securities for employees
8:33am
S-8
EX-99.1
9ecsxe6b
9 Feb 24
Registration of securities for employees
8:33am
424B3
t77ao3aw n1ee8nxxe
1 Feb 24
Prospectus supplement
4:42pm
424B3
ow945x
2 Jan 24
Prospectus supplement
4:30pm
8-K
qhjokruyfo
21 Dec 23
Spectral AI Names Industry Veteran and Former Top MiMedx Financial Executive Peter M. Carlson as CFO
12:29pm